Pharmaceuticals

Plasma Fractionation Industry Overview 2025: Growth Projections and Market Trends

November 7, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Future Market Size Estimation For The Plasma Fractionation Market Covering 2025–2034?

The plasma fractionation market has experienced significant expansion in recent years. Forecasts indicate it will surge from $31.42 billion in 2024 to $34.14 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 8.6%. This historical development is primarily due to the rising prevalence of hemophilia and immunodeficiency disorders, an expanding aging demographic, an increasing need for immunoglobulins, the spread of plasma collection centers, and an uptick in surgical procedures.

The plasma fractionation market size is anticipated to experience substantial expansion in the coming years. By 2029, it is projected to attain a valuation of $50.54 billion, demonstrating a compound annual growth rate (CAGR) of 10.3%. This growth over the forecast period stems from factors such as increasing global healthcare expenditure, broader applications of plasma-derived medicinal products, heightened investment in research and development, a rising need for plasma in treating neurological disorders, and the expansion of plasma fractionation facilities. Significant developments expected during this timeframe encompass the creation of novel fractionation technologies, a pivot towards albumin and immunoglobulin therapies, an escalating demand for specialty plasma products, a dedicated focus on pathogen inactivation technologies, and strategic alliances and partnerships within the plasma industry.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7543&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Plasma Fractionation Industry?

The growing prevalence of chronic diseases is anticipated to drive the expansion of the plasma fractionation market. These are conditions persisting for a year or longer, necessitating continuous medical care, with examples encompassing heart disease, cancer, and diabetes. Utilizing plasma products for treating individuals with chronic ailments lessens illness severity, enhances life quality, and proves economical, consequently boosting the demand for plasma fractionation. As an illustration, a report released in January 2023 by the National Library of Medicine, a US-based agency, indicates that the population aged 50 and above in the United States suffering from one or more chronic conditions is forecast to increase by 99.5%, escalating from 71.522 million in 2020 to 142.66 million by 2050. Thus, the rising incidence of chronic diseases is fueling the growth of the healthcare analytical testing service market. Consequently, an expanding number of chronic diseases across all age groups is poised to advance the plasma fractionation market growth.

What Are The Major Segments Identified In The Plasma Fractionation Market?

The plasma fractionation market covered in this report is segmented –

1) By Product: Immunoglobulins, Coagulation Factors, Albumin, Protease Inhibitors

2) By Application: Immunology, Hematology, Neurology, Critical Care, Hemato-Oncology, Rheumatology

3) By End User: Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes

Subsegments:

1) By Immunoglobulins: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)

2) By Coagulation Factors: Factor VIII, Factor IX, Prothrombin Complex Concentrates (PCC)

3) By Albumin: Human Albumin, Bovine Serum Albumin (BSA)

4) By Protease Inhibitors: Alpha-1 Antitrypsin (AAT), C1 Esterase Inhibitor (C1-INH)

What Trends Are Redefining The Plasma Fractionation Market Dynamics?

Major companies within the market are implementing new technologies, such as advanced facility processes that transform donated human plasma into essential medicines, making the procedure more efficient and secure. For instance, in March 2023, the German-based company CSL Behring inaugurated a new $470 million plasma fractionation facility. This facility incorporates cutting-edge technology to enhance the efficiency and safety of plasma processing, thereby ensuring higher quality and more reliable medicines. By expanding the supply of these critical medicines, the facility helps to satisfy the increasing demand, ensuring a greater number of patients have access to life-saving treatments. Additionally, its advanced automation and self-cleaning systems reduce the potential for contamination and improve overall hygienic conditions, further enhancing patient safety.

Which Leading Companies Dominate The Plasma Fractionation Market Share?

Major companies operating in the plasma fractionation market include Baxter International Inc., Bio Products Laboratory Limited, Biotest AG, CSL Limited, Grifols S. A, ADMA Biologics Inc., Green Cross Corporation, Hualan Bioengineering Inc., Intas Pharmaceuticals Ltd., Japan Blood Products Organization, Kedrion S. P. A., Kamada Ltd., LFB Biomedicaments S. A. S, Octapharma AG, Sanquin Plasma Products B. V., Shanghai Raas Blood Products Co. Ltd., Takeda Pharmaceutical Company, Terumo BCT, China Biologic Products Holdings Inc., China National Biotec Group, Emergent BioSolutions Inc., Bharat Serum Vaccines Limited, Plasma Therapeutics, Prothya Biosolutions B. V., BioPharma Plasma LLC, BioLife Plasma Services LP

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report

What Regional Growth Trends Are Shaping The Plasma Fractionation Market Outlook?

North America was the largest region in the plasma fractionation market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma fractionation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Plasma Fractionation Market Report:

https://www.thebusinessresearchcompany.com/customise?id=7543&type=smp

Browse Through More Reports Similar to the Global Plasma Fractionation Market 2025, By The Business Research Company

Blood And Blood Components Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-global-market-report

Convalescent Plasma Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/convalescent-plasma-therapy-global-market-report

Patient Blood Management Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795